For individuals with chronic low back pain (cLBP), body mass index (BMI) is not significantly associated with self-reported pain and disability.
Orexigen announced that it has resubmitted an NDA to the FDA for Contrave (naltrexone sustained release [SR]/bupropion SR), an investigational drug for weight loss and maintenance of weight loss.
The FDA has granted a 6-month Priority Review designation to Genzyme's New Drug Application (NDA) for Cerdelga (eliglustat), an investigational oral therapy for adults with Gaucher disease type 1.
Greater body weight satisfaction was associated with greater relationship satisfaction and self-esteem and lower body image self-consciousness.
For extremely obese women, predictors of cesarean delivery (CD) include body mass index (BMI), as well as maternal age, parity, and cervical dilation at the time of admission.
This CME/CEU activity is designed to give clinicians a better understanding of the pharmacology, indications, contraindications, benefits/risk and ...1.00 AMA PRA Category 1 Credit(s)TM
This activity will describe the various techniques that practitioners can use to help patients make lifestyle and self-care ...1.00 CE for Nurses
Primary care clinicians oversee the management of most patients who have diabetes or are at risk to develop ...1.00 AMA PRA Category 1 Credit(s)TM